In a desperate attempt to salvage ACA tax credits amidst a looming government shutdown, House Democrats are launching a discharge petition. This risky tactic may require Republican support to succeed, but will it work?
As the House prepares to vote on a bill to end the longest government shutdown in U.S. history, tensions rise over the failure to extend healthcare subsidies. Will bipartisan support seal the deal?
The US Senate is poised to vote on a funding bill that could end the 40-day government shutdown. However, tensions rise as Democrats demand healthcare reforms. Will a compromise be reached in time for Thanksgiving?
Tesla's recent earnings report shows a dip in profits due to tariffs, declining regulatory credits, and increased operating costs. As competition rises and tax credits fade, will Tesla's strategy hold up? Discover the latest insights.
California is investing $342 million in tax credits to revive its film industry, including significant funding for the next Jumanji installment and other major projects, aiming to counter a production downturn.
As the federal shutdown drags on, it highlights the GOP's struggles with health care policy. With Democrats holding firm on Affordable Care Act tax credits, Republicans face pressure over their health care stance.
As the government shutdown drags on, Senate Democrats remain resolute in their demands for health care benefits, leaving hundreds of thousands of federal workers in limbo and causing widespread flight delays.
In a surprising twist, Jimmy Kimmel praises Marjorie Taylor Greene for her stance on healthcare amid the government shutdown, breaking from party lines as she addresses rising insurance premiums.
As the government shutdown continues, lawmakers face a critical decision on extending subsidies for the Affordable Care Act. With millions at stake, the urgency mounts for bipartisan action before open enrollment begins.
Tesla has ramped up sales with discounts and financing deals before the $7,500 federal tax credit expires. But analysts warn this surge may not last, raising questions about the company's future.